Table of Contents 1 Liposome Drug Delivery Market Overview 1.1 Product Overview and Scope of Liposome Drug Delivery 1.2 Liposome Drug Delivery Segment by Type 1.2.1 Global Liposome Drug Delivery Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Liposomal Doxorubicin 1.2.3 Liposomal Amphoteracin B 1.2.4 Liposomal Paclitaxel 1.2.5 Others 1.3 Liposome Drug Delivery Segment by Application 1.3.1 Liposome Drug Delivery Sales Comparison by Application: 2020 VS 2026 1.3.2 Fungal Infection Therapy 1.3.3 Cancer & Tumor Therapy 1.3.4 Others 1.4 Global Liposome Drug Delivery Market Size Estimates and Forecasts 1.4.1 Global Liposome Drug Delivery Revenue 2015-2026 1.4.2 Global Liposome Drug Delivery Sales 2015-2026 1.4.3 Liposome Drug Delivery Market Size by Region: 2020 Versus 2026 2 Global Liposome Drug Delivery Market Competition by Manufacturers 2.1 Global Liposome Drug Delivery Sales Market Share by Manufacturers (2015-2020) 2.2 Global Liposome Drug Delivery Revenue Share by Manufacturers (2015-2020) 2.3 Global Liposome Drug Delivery Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Liposome Drug Delivery Manufacturing Sites, Area Served, Product Type 2.5 Liposome Drug Delivery Market Competitive Situation and Trends 2.5.1 Liposome Drug Delivery Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Liposome Drug Delivery Players (Opinion Leaders) 3 Liposome Drug Delivery Retrospective Market Scenario by Region 3.1 Global Liposome Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Liposome Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Liposome Drug Delivery Market Facts & Figures by Country 3.3.1 North America Liposome Drug Delivery Sales by Country 3.3.2 North America Liposome Drug Delivery Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Liposome Drug Delivery Market Facts & Figures by Country 3.4.1 Europe Liposome Drug Delivery Sales by Country 3.4.2 Europe Liposome Drug Delivery Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Liposome Drug Delivery Market Facts & Figures by Region 3.5.1 Asia Pacific Liposome Drug Delivery Sales by Region 3.5.2 Asia Pacific Liposome Drug Delivery Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Liposome Drug Delivery Market Facts & Figures by Country 3.6.1 Latin America Liposome Drug Delivery Sales by Country 3.6.2 Latin America Liposome Drug Delivery Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country 3.7.1 Middle East and Africa Liposome Drug Delivery Sales by Country 3.7.2 Middle East and Africa Liposome Drug Delivery Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Liposome Drug Delivery Historic Market Analysis by Type 4.1 Global Liposome Drug Delivery Sales Market Share by Type (2015-2020) 4.2 Global Liposome Drug Delivery Revenue Market Share by Type (2015-2020) 4.3 Global Liposome Drug Delivery Price Market Share by Type (2015-2020) 4.4 Global Liposome Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Liposome Drug Delivery Historic Market Analysis by Application 5.1 Global Liposome Drug Delivery Sales Market Share by Application (2015-2020) 5.2 Global Liposome Drug Delivery Revenue Market Share by Application (2015-2020) 5.3 Global Liposome Drug Delivery Price by Application (2015-2020) 6 Company Profiles and Key Figures in Liposome Drug Delivery Business 6.1 Gilead Sciences 6.1.1 Corporation Information 6.1.2 Gilead Sciences Description, Business Overview and Total Revenue 6.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Gilead Sciences Products Offered 6.1.5 Gilead Sciences Recent Development 6.2 Pacira 6.2.1 Pacira Liposome Drug Delivery Production Sites and Area Served 6.2.2 Pacira Description, Business Overview and Total Revenue 6.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pacira Products Offered 6.2.5 Pacira Recent Development 6.3 Sun Pharmaceutical 6.3.1 Sun Pharmaceutical Liposome Drug Delivery Production Sites and Area Served 6.3.2 Sun Pharmaceutical Description, Business Overview and Total Revenue 6.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Sun Pharmaceutical Products Offered 6.3.5 Sun Pharmaceutical Recent Development 6.4 Johnson & Johnson 6.4.1 Johnson & Johnson Liposome Drug Delivery Production Sites and Area Served 6.4.2 Johnson & Johnson Description, Business Overview and Total Revenue 6.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Johnson & Johnson Products Offered 6.4.5 Johnson & Johnson Recent Development 6.5 Luye Pharma 6.5.1 Luye Pharma Liposome Drug Delivery Production Sites and Area Served 6.5.2 Luye Pharma Description, Business Overview and Total Revenue 6.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Luye Pharma Products Offered 6.5.5 Luye Pharma Recent Development 6.6 Sigma-Tau 6.6.1 Sigma-Tau Liposome Drug Delivery Production Sites and Area Served 6.6.2 Sigma-Tau Description, Business Overview and Total Revenue 6.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Sigma-Tau Products Offered 6.6.5 Sigma-Tau Recent Development 6.7 Ipsen (Onivyde) 6.6.1 Ipsen (Onivyde) Liposome Drug Delivery Production Sites and Area Served 6.6.2 Ipsen (Onivyde) Description, Business Overview and Total Revenue 6.6.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Ipsen (Onivyde) Products Offered 6.7.5 Ipsen (Onivyde) Recent Development 6.8 CSPC 6.8.1 CSPC Liposome Drug Delivery Production Sites and Area Served 6.8.2 CSPC Description, Business Overview and Total Revenue 6.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.8.4 CSPC Products Offered 6.8.5 CSPC Recent Development 6.9 Teva Pharmaceutical 6.9.1 Teva Pharmaceutical Liposome Drug Delivery Production Sites and Area Served 6.9.2 Teva Pharmaceutical Description, Business Overview and Total Revenue 6.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Teva Pharmaceutical Products Offered 6.9.5 Teva Pharmaceutical Recent Development 6.10 Novartis 6.10.1 Novartis Liposome Drug Delivery Production Sites and Area Served 6.10.2 Novartis Description, Business Overview and Total Revenue 6.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Novartis Products Offered 6.10.5 Novartis Recent Development 6.11 Fudan-Zhangjiang 6.11.1 Fudan-Zhangjiang Liposome Drug Delivery Production Sites and Area Served 6.11.2 Fudan-Zhangjiang Liposome Drug Delivery Description, Business Overview and Total Revenue 6.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Fudan-Zhangjiang Products Offered 6.11.5 Fudan-Zhangjiang Recent Development 7 Liposome Drug Delivery Manufacturing Cost Analysis 7.1 Liposome Drug Delivery Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Liposome Drug Delivery 7.4 Liposome Drug Delivery Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Liposome Drug Delivery Distributors List 8.3 Liposome Drug Delivery Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Liposome Drug Delivery Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Liposome Drug Delivery by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Liposome Drug Delivery by Type (2021-2026) 10.2 Liposome Drug Delivery Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Liposome Drug Delivery by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Liposome Drug Delivery by Application (2021-2026) 10.3 Liposome Drug Delivery Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Liposome Drug Delivery by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Liposome Drug Delivery by Region (2021-2026) 10.4 North America Liposome Drug Delivery Estimates and Projections (2021-2026) 10.5 Europe Liposome Drug Delivery Estimates and Projections (2021-2026) 10.6 Asia Pacific Liposome Drug Delivery Estimates and Projections (2021-2026) 10.7 Latin America Liposome Drug Delivery Estimates and Projections (2021-2026) 10.8 Middle East and Africa Liposome Drug Delivery Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Liposome Drug Delivery Sales (K Vial) Growth Rate Comparison by Type (2015-2026) Table 2. Global Liposome Drug Delivery Sales (K Vial) Comparison by Application: 2020 VS 2026 Table 3. Global Liposome Drug Delivery Market Size by Type (K Vial) (US$ Million) (2020 VS 2026) Table 4. Global Key Liposome Drug Delivery Manufacturers Covered in This Study Table 5. Global Liposome Drug Delivery Sales (K Vial) by Manufacturers (2015-2020) Table 6. Global Liposome Drug Delivery Sales Share by Manufacturers (2015-2020) Table 7. Global Liposome Drug Delivery Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Liposome Drug Delivery Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Liposome Drug Delivery Average Price (USD/Vial) of Key Manufacturers (2015-2020) Table 10. Manufacturers Liposome Drug Delivery Sales Sites and Area Served Table 11. Manufacturers Liposome Drug Delivery Product Types Table 12. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Drug Delivery as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Liposome Drug Delivery Players Table 16. Global Liposome Drug Delivery Sales (K Vial) by Region (2015-2020) Table 17. Global Liposome Drug Delivery Sales Market Share by Region (2015-2020) Table 18. Global Liposome Drug Delivery Revenue (Million US$) by Region (2015-2020) Table 19. Global Liposome Drug Delivery Revenue Market Share by Region (2015-2020) Table 20. North America Liposome Drug Delivery Sales by Country (2015-2020) (K Vial) Table 21. North America Liposome Drug Delivery Sales Market Share by Country (2015-2020) Table 22. North America Liposome Drug Delivery Revenue by Country (2015-2020) (US$ Million) Table 23. North America Liposome Drug Delivery Revenue Market Share by Country (2015-2020) Table 24. Europe Liposome Drug Delivery Sales by Country (2015-2020) (K Vial) Table 25. Europe Liposome Drug Delivery Sales Market Share by Country (2015-2020) Table 26. Europe Liposome Drug Delivery Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Liposome Drug Delivery Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Liposome Drug Delivery Sales by Region (2015-2020) (K Vial) Table 29. Asia Pacific Liposome Drug Delivery Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Liposome Drug Delivery Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Liposome Drug Delivery Revenue Market Share by Region (2015-2020) Table 32. Latin America Liposome Drug Delivery Sales by Country (2015-2020) (K Vial) Table 33. Latin America Liposome Drug Delivery Sales Market Share by Country (2015-2020) Table 34. Latin America Liposome Drug Delivery Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Liposome Drug Delivery Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Liposome Drug Delivery Sales by Country (2015-2020) (K Vial) Table 37. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Liposome Drug Delivery Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2015-2020) Table 40. Global Liposome Drug Delivery Sales (K Vial) by Type (2015-2020) Table 41. Global Liposome Drug Delivery Sales Share by Type (2015-2020) Table 42. Global Liposome Drug Delivery Revenue (Million US$) by Type (2015-2020) Table 43. Global Liposome Drug Delivery Revenue Share by Type (2015-2020) Table 44. Global Liposome Drug Delivery Price (USD/Vial) by Type (2015-2020) Table 45. Global Liposome Drug Delivery Sales (K Vial) by Application (2015-2020) Table 46. Global Liposome Drug Delivery Sales Market Share by Application (2015-2020) Table 47. Global Liposome Drug Delivery Sales Growth Rate by Application (2015-2020) Table 48. Gilead Sciences Liposome Drug Delivery Corporation Information Table 49. Gilead Sciences Description and Business Overview Table 50. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 51. Gilead Sciences Main Product Table 52. Gilead Sciences Recent Development Table 53. Pacira Liposome Drug Delivery Corporation Information Table 54. Pacira Corporation Information Table 55. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 56. Pacira Main Product Table 57. Pacira Recent Development Table 58. Sun Pharmaceutical Liposome Drug Delivery Corporation Information Table 59. Sun Pharmaceutical Corporation Information Table 60. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 61. Sun Pharmaceutical Main Product Table 62. Sun Pharmaceutical Recent Development Table 63. Johnson & Johnson Liposome Drug Delivery Corporation Information Table 64. Johnson & Johnson Corporation Information Table 65. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 66. Johnson & Johnson Main Product Table 67. Johnson & Johnson Recent Development Table 68. Luye Pharma Liposome Drug Delivery Corporation Information Table 69. Luye Pharma Corporation Information Table 70. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 71. Luye Pharma Main Product Table 72. Luye Pharma Recent Development Table 73. Sigma-Tau Liposome Drug Delivery Corporation Information Table 74. Sigma-Tau Corporation Information Table 75. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 76. Sigma-Tau Main Product Table 77. Sigma-Tau Recent Development Table 78. Ipsen (Onivyde) Liposome Drug Delivery Corporation Information Table 79. Ipsen (Onivyde) Corporation Information Table 80. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 81. Ipsen (Onivyde) Main Product Table 82. Ipsen (Onivyde) Recent Development Table 83. CSPC Liposome Drug Delivery Corporation Information Table 84. CSPC Corporation Information Table 85. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 86. CSPC Main Product Table 87. CSPC Recent Development Table 88. Teva Pharmaceutical Liposome Drug Delivery Corporation Information Table 89. Teva Pharmaceutical Corporation Information Table 90. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 91. Teva Pharmaceutical Main Product Table 92. Teva Pharmaceutical Recent Development Table 93. Novartis Liposome Drug Delivery Corporation Information Table 94. Novartis Corporation Information Table 95. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 96. Novartis Main Product Table 97. Novartis Recent Development Table 98. Fudan-Zhangjiang Liposome Drug Delivery Corporation Information Table 99. Fudan-Zhangjiang Corporation Information Table 100. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020) Table 101. Fudan-Zhangjiang Main Product Table 102. Fudan-Zhangjiang Recent Development Table 103. Sales Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Liposome Drug Delivery Distributors List Table 106. Liposome Drug Delivery Customers List Table 107. Market Key Trends Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 109. Key Challenges Table 110. Global Liposome Drug Delivery Sales (K Vial) Forecast by Type (2021-2026) Table 111. Global Liposome Drug Delivery Sales Market Share Forecast by Type (2021-2026) Table 112. Global Liposome Drug Delivery Revenue (Million US$) Forecast by Type (2021-2026) Table 113. Global Liposome Drug Delivery Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 114. Global Liposome Drug Delivery Sales (K Vial) Forecast by Application (2021-2026) Table 115. Global Liposome Drug Delivery Revenue (Million US$) Forecast by Application (2021-2026) Table 116. Global Liposome Drug Delivery Sales (K Vial) Forecast by Region (2021-2026) Table 117. Global Liposome Drug Delivery Sales Market Share Forecast by Region (2021-2026) Table 118. Global Liposome Drug Delivery Revenue Forecast by Region (2021-2026) (US$ Million) Table 119. Global Liposome Drug Delivery Revenue Market Share Forecast by Region (2021-2026) Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Liposome Drug Delivery Figure 2. Global Liposome Drug Delivery Sales Market Share by Type: 2020 VS 2026 Figure 3. Liposomal Doxorubicin Product Picture Figure 4. Liposomal Amphoteracin B Product Picture Figure 5. Liposomal Paclitaxel Product Picture Figure 6. Others Product Picture Figure 7. Global Liposome Drug Delivery Consumption Market Share by Application: 2020 VS 2026 Figure 8. Fungal Infection Therapy Figure 9. Cancer & Tumor Therapy Figure 10. Others Figure 11. Global Liposome Drug Delivery Market Size 2015-2026 (US$ Million) Figure 12. Global Liposome Drug Delivery Sales Capacity (K Vial) (2015-2026) Figure 13. Global Liposome Drug Delivery Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Liposome Drug Delivery Sales Share by Manufacturers in 2020 Figure 15. Global Liposome Drug Delivery Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Liposome Drug Delivery Revenue in 2019 Figure 17. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Liposome Drug Delivery Sales Market Share by Region (2015-2020) Figure 19. Global Liposome Drug Delivery Sales Market Share by Region in 2019 Figure 20. Global Liposome Drug Delivery Revenue Market Share by Region (2015-2020) Figure 21. Global Liposome Drug Delivery Revenue Market Share by Region in 2019 Figure 22. North America Liposome Drug Delivery Sales Market Share by Country in 2019 Figure 23. North America Liposome Drug Delivery Revenue Market Share by Country in 2019 Figure 24. U.S. Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 25. U.S. Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 27. Canada Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Liposome Drug Delivery Sales Market Share by Country in 2019 Figure 29. Europe Liposome Drug Delivery Revenue Market Share by Country in 2019 Figure 30. Germany Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 31. Germany Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 33. France Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 35. U.K. Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 37. Italy Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 39. Russia Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Liposome Drug Delivery Sales Market Share by Region in 2019 Figure 41. Asia Pacific Liposome Drug Delivery Revenue Market Share by Region in 2019 Figure 42. China Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 43. China Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 45. Japan Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 47. South Korea Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 49. India Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 51. Australia Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 53. Taiwan Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 55. Indonesia Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 57. Thailand Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 59. Malaysia Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 61. Philippines Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 63. Vietnam Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Liposome Drug Delivery Sales Market Share by Country in 2019 Figure 65. Latin America Liposome Drug Delivery Revenue Market Share by Country in 2019 Figure 66. Mexico Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 67. Mexico Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 69. Brazil Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 71. Argentina Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country in 2019 Figure 74. Turkey Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 75. Turkey Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 77. Saudi Arabia Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Liposome Drug Delivery Sales Growth Rate (2015-2020) (K Vial) Figure 79. U.A.E Liposome Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Liposome Drug Delivery by Type (2015-2020) Figure 81. Sales Market Share of Liposome Drug Delivery by Type in 2019 Figure 82. Revenue Share of Liposome Drug Delivery by Type (2015-2020) Figure 83. Revenue Market Share of Liposome Drug Delivery by Type in 2019 Figure 84. Global Liposome Drug Delivery Sales Growth by Type (2015-2020) (K Vial) Figure 85. Global Liposome Drug Delivery Sales Market Share by Application (2015-2020) Figure 86. Global Liposome Drug Delivery Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Liposome Drug Delivery by Application (2015-2020) Figure 88. Global Revenue Share of Liposome Drug Delivery by Application in 2020 Figure 89. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Pacira Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Luye Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Sigma-Tau Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Ipsen (Onivyde) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. CSPC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Fudan-Zhangjiang Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Price Trend of Key Raw Materials Figure 101. Manufacturing Cost Structure of Liposome Drug Delivery Figure 102. Manufacturing Process Analysis of Liposome Drug Delivery Figure 103. Liposome Drug Delivery Industrial Chain Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Porter's Five Forces Analysis Figure 107. North America Liposome Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026) Figure 108. North America Liposome Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Europe Liposome Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026) Figure 110. Europe Liposome Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Liposome Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Liposome Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Liposome Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Liposome Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Liposome Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Liposome Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Bottom-up and Top-down Approaches for This Report Figure 118. Data Triangulation Figure 119. Key Executives Interviewed

Gilead Sciences Pacira Sun Pharmaceutical Johnson & Johnson Luye Pharma Sigma-Tau Ipsen (Onivyde) CSPC Teva Pharmaceutical Novartis Fudan-Zhangjiang